Cirrhotic Cardiomyopathy in the Era of Liver Transplantation: Time for Precise Stepwise Evaluation

Area of Science:

• Cardiology
• Hepatology
• Medical Diagnostics

Background:

• Liver cirrhosis (LC) significantly impacts mortality, with liver transplantation (LT) improving outcomes.
• Cardiac dysfunction is a primary cause of post-LT mortality, necessitating thorough pre-transplant cardiac evaluation.
• Current guidelines lack specific recommendations for cirrhotic cardiomyopathy (CCM), a condition complicating LC and LT.

Purpose of the Study:

• To review diagnostic techniques for cirrhotic cardiomyopathy (CCM).
• To evaluate the diagnostic and prognostic roles of traditional and novel methods for CCM.
• To propose an improved algorithm for CCM detection in liver cirrhosis patients.

Main Methods:

• Review of existing literature on cirrhotic cardiomyopathy (CCM) diagnosis.
• Analysis of traditional echocardiography techniques.
• Evaluation of novel methods like tissue Doppler imaging and speckle tracking echocardiography.

Main Results:

• Cirrhotic cardiomyopathy (CCM) involves cardiac dysfunction (systolic/diastolic/electrophysiological) unrelated to other cardiac diseases.
• Novel echocardiography methods show promise for early CCM detection and have prognostic implications.
• Existing guidelines inadequately address CCM evaluation pre-LT.

Conclusions:

• Early detection of cirrhotic cardiomyopathy (CCM) is crucial for improving liver transplant outcomes.
• Novel echocardiography techniques are essential for accurate CCM diagnosis and risk stratification.
• A refined diagnostic algorithm is needed to better identify cardiac dysfunction in liver cirrhosis patients.